Quantification of lipid mediator metabolites in human urine from asthma patients by electrospray ionization mass spectrometry: controlling matrix effects.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Analytical Chemistry

• Publication date

  2013-08-07

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/ac401461bPMID 23863083
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Application of ’omics technologies to biomarker discovery in inflammatory lung diseases

  2013cited by this paper
• A ultra-pressure liquid chromatography/triple quadrupole tandem mass spectrometry method for the analysis of 13 eicosanoids in human urine and quantitative 24 hour values in healthy volunteers in a controlled constant diet.

  2012cited by this paper
• A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoids

  2012cited by this paper
• Annotation of the human adult urinary metabolome and metabolite identification using ultra high performance liquid chromatography coupled to a linear quadrupole ion trap-Orbitrap mass spectrometer.

  2012cited by this paper
• Lipid mediator profiling in pulmonary disease.

  2011cited by this paper
• Prostaglandins and Inflammation

  2011cited by this paper
• Leukotriene antagonists as first-line or add-on asthma-controller therapy.

  2011cited by this paper
• Effects of celecoxib on major prostaglandins in asthma

  2011cited by this paper
• Recent and potential developments in the analysis of urine: a review.

  2011cited by this paper
• A significant proportion of F2-isoprostanes in human urine are excreted as glucuronide conjugates.

  2010cited by this paper
• Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry.

  2009cited by this paper
• Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation.

  2009cited by this paper
• Normalization strategies for metabonomic analysis of urine samples.

  2009cited by this paper
• Systems biology: Metabonomics

  2008cited by this paper
• Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells

  2008cited by this paper
• Lipid signalling in disease

  2008cited by this paper
• Liquid chromatography-tandem mass spectrometric quantification of the dehydration product of tetranor PGE-M, the major urinary metabolite of prostaglandin E(2) in human urine.

  2008cited by this paper
• Beyond prostaglandins--chemistry and biology of cyclic oxygenated metabolites formed by free-radical pathways from polyunsaturated fatty acids.

  2008cited by this paper
• Biosynthesis and metabolism of leukotrienes.

  2007cited by this paper
• Urinary Prostaglandin F2α Is Generated from the Isoprostane Pathway and Not the Cyclooxygenase in Humans*

  2007cited by this paper
• Noninvasive assessment of the role of cyclooxygenases in cardiovascular health: a detailed HPLC/MS/MS method.

  2007cited by this paper
• Reactive oxidant species in asthma

  2006cited by this paper
• Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry.

  2005cited by this paper
• Total synthesis of isoprostanes: discovery and quantitation in biological systems.

  2004cited by this paper
• Urinary Creatinine Concentrations in the U.S. Population: Implications for Urinary Biologic Monitoring Measurements

  2004cited by this paper
• The lung as a privileged site for the beneficial actions of PGE2.

  2004cited by this paper
• Comparison of uncertainties related to standardization of urine samples with volume and creatinine concentration.

  2004cited by this paper
• Synthesis and metabolism of leukotrienes in γ-glutamyl transpeptidase deficiency Published, JLR Papers in Press, February 1, 2004. DOI 10.1194/jlr.M300462-JLR200

  2004cited by this paper
• Synthesis and metabolism of leukotrienes in gamma-glutamyl transpeptidase deficiency.

  2004cited by this paper
• Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling.

  2003cited by this paper
• Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS.

  2003cited by this paper
• Urinary Metabolites of Leukotriene B4 in the Human Subject*

  2003cited by this paper
• The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS DOI 10.1194/jlr.D200018-JLR200

  2002cited by this paper
• Prostaglandins and leukotrienes: advances in eicosanoid biology.

  2001cited by this paper
• Measurement of urinary concentration: a critical appraisal of methodologies

  2001cited by this paper
• Allergen-induced synthesis of F(2)-isoprostanes in atopic asthmatics. Evidence for oxidant stress.

  1999cited by this paper
• Analyses of prostaglandin D2 metabolites in urine: comparison between enzyme immunoassay and negative ion chemical ionisation gas chromatography-mass spectrometry.

  1999cited by this paper
• Syntheses and identification of the most abundant urinary type VI isoprostanes

  1998cited by this paper
• Metabolism of 8-iso-prostaglandin F2alpha.

  1998cited by this paper
• Can asthma be studied in the urine?

  1998cited by this paper
• Metabolism of 8‐iso‐prostaglandin F2α

  1998cited by this paper
• Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics.

  1997cited by this paper
• Urinary excretion of leukotriene E4 and 11-dehydrothromboxane B2 in patients with spontaneous asthma attacks.

  1997cited by this paper
• Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction.

  1996cited by this paper
• Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.

  1992cited by this paper
• Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics.

  1992cited by this paper
• Thromboxane A2 biosynthesis in acute asthma and after antigen challenge.

  1991cited by this paper
• Leukotriene E4 elimination and metabolism in normal human subjects.

  1990cited by this paper
• Urinary prostaglandins and seminal fluid contamination.

  1982cited by this paper
• Prostaglandins and the kidney.

  1977cited by this paper
• Quantifications of the major urinary metabolite of the E prostaglandins by mass spectrometry: evaluation of the method's application to clinical studies.

  1976cited by this paper
• Identification and assay of tetranor-prostaglandin E1 in human urine.

  1976cited by this paper
• The structure of the major urinary metabolite of prostaglandin E2 in man.

  1969cited by this paper
• The structure of a urinary metabolite of prostaglandin F2a in man.

  1969cited by this paper

• Arachidonic Acid Metabolites in Self-collected Biospecimens Following Campfire Exposure: Exploring Non-invasive Biomarkers of Wildfire Health Effects.

  2024cites this paper
• Comprehensive analysis of oxylipins using reverse phase liquid chromatography and data dependent acquisition workflow on LTQ-Orbitrap® Velos Pro.

  2023cites this paper
• A single extraction 96-well method for LC-MS/MS quantification of urinary eicosanoids, steroids and drugs.

  2023cites this paper
• Prostanoid Metabolites as Biomarkers in Human Disease

  2022cites this paper
• Exploring Unexplored Biomarkers of Oxidative Distress and their Use

  2021cites this paper
• The roles of lipid mediators in type I hypersensitivity.

  2021cites this paper
• Determination of urinary prostaglandin E2 as a potential biomarker of ureteral stent associated inflammation.

  2020cites this paper
• Methods of the Analysis of Oxylipins in Biological Samples

  2020cites this paper
• Urinary leukotriene E 4 and prostaglandin D 2 metabolites increase in adult and 1 childhood severe asthma characterized by type-2 inflammation 2 3

  2020cites this paper
• Fluorous-paired derivatization approach towards highly sensitive and accurate determination of long chain unsaturated fatty acids by liquid chromatography-tandem mass spectrometry.

  2020cites this paper
• Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study

  2020cites this paper
• Epithelial Barrier Dysfunction in Type 2 Inflammatory Diseases

  2019cites this paper
• Determination of potential childhood asthma biomarkers using a powerful methodology based on microextraction by packed sorbent combined with ultra-high pressure liquid chromatography. Eicosanoids as case study.

  2019cites this paper
• Quantitative determination of potential urine biomarkers of respiratory illnesses using new targeted metabolomic approach.

  2019cites this paper
• Quantitative metabolic profiling of urinary eicosanoids for clinical phenotyping[S]

  2019cites this paper
• Modern Methods of Sample Preparation for the Analysis of Oxylipins in Biological Samples

  2019cites this paper
• Bronchoprovocation studies to define mechanisms in asthma and airway inflammation

  2019cites this paper
• Comparative analysis of creatinine and osmolality as urine normalization strategies in targeted metabolomics for the differential diagnosis of asthma and COPD

  2018cites this paper
• Leukotriene E4 induces airflow obstruction and mast cell activation through the cysteinyl leukotriene type 1 receptor

  2018cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1417 High Blood Pressure in Children with Hydronephrosis

  2018cites this paper
• U-BIOPRED: evaluation of the value of a public-private partnership to industry.

  2018cites this paper
• Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort

  2018cites this paper
• Quantification of eicosanoids and their metabolites in biological matrices: a review.

  2018cites this paper
• Quantification of Lipids: Model, Reality, and Compromise

  2018cites this paper
• House dust mite drives proinflammatory eicosanoid reprogramming and macrophage effector functions

  2018cites this paper
• A powerful strategy based on targeted analysis for detection of asthma biomarkers: the challenge for miniaturization

  2018cites this paper
• Aronia-citrus juice (polyphenol-rich juice) intake and elite triathlon training: a lipidomic approach using representative oxylipins in urine.

  2018cites this paper
• Type 2 Inflammation and the Evolving Profile of Uncontrolled Persistent Asthma

  2018cites this paper
• Changes in arterial pressure and markers of nitric oxide homeostasis and oxidative stress following surgical correction of hydronephrosis in children

  2017cites this paper
• Matrix-effect free quantitative liquid chromatography mass spectrometry analysis in complex matrices using nanoflow LC with integrated emitter tip and high dilution factors.

  2017cites this paper
• Dynamic Assessment of Functional Lipidomic Analysis in Human Urine

  2016cites this paper
• Direct analysis of prostaglandin-E2 and -D2 produced in an inflammatory cell reaction and its application for activity screening and potency evaluation using turbulent flow chromatography liquid chromatography-high resolution mass spectrometry.

  2016cites this paper
• Biomarkers for the Phenotyping and Monitoring of Asthma in Children

  2016cites this paper
• Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD

  2016cites this paper
• Leukotrienes as Biomarkers of Cardiovascular Disease

  2016cites this paper
• Urinary excretion of lipid mediators in response

  2015cites this paper
• Studies of exercise-induced bronchoconstriction to define protective mechanisms in asthma

  2015cites this paper
• The isoprostanes--25 years later.

  2015cites this paper
• Tandem Benzophenone Amino Pyridines, Potent and Selective Inhibitors of Human Leukotriene C4 Synthase

  2015cites this paper
• The effect of omega-3 fatty acids on bronchial hyperresponsiveness, sputum eosinophilia, and mast cell mediators in asthma.

  2015cites this paper
• Determination of ω-6 and ω-3 PUFA metabolites in human urine samples using UPLC/MS/MS

  2015cites this paper
• Bioanalytical insights into mediator lipidomics.

  2015cites this paper
• Urinary excretion of lipid mediators in response to repeated eucapnic voluntary hyperpnea in asthmatic subjects.

  2015cites this paper
• A comprehensive quantification method for eicosanoids and related compounds by using liquid chromatography/mass spectrometry with high speed continuous ionization polarity switching.

  2015cites this paper
• Liquid chromatography-tandem mass spectrometry for the analysis of eicosanoids and related lipids in human biological matrices: a review.

  2014cites this paper
• Liquid chromatography-tandem mass spectrometry analysis of eicosanoids and related compounds in cell models.

  2014cites this paper
• Liquid chromatography-mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases.

  2014cites this paper
• Effects of selective COX-2 inhibition on allergen-induced bronchoconstriction and airway inflammation in asthma.

  2014cites this paper
• Quantitative metabolic profiling of lipid mediators.

  2013cites this paper
• Quantitation of oxylipins in biological samples, focusing on plasma and urine.

  year unknowncites this paper